DK0509086T3 - Fremgangsmåde til bestemmelse af koncentrationen af antikoagulanter - Google Patents
Fremgangsmåde til bestemmelse af koncentrationen af antikoagulanterInfo
- Publication number
- DK0509086T3 DK0509086T3 DK92900357.2T DK92900357T DK0509086T3 DK 0509086 T3 DK0509086 T3 DK 0509086T3 DK 92900357 T DK92900357 T DK 92900357T DK 0509086 T3 DK0509086 T3 DK 0509086T3
- Authority
- DK
- Denmark
- Prior art keywords
- anticoagulatory
- concentration
- thrombin
- inhibition
- anticoagulants
- Prior art date
Links
- 239000003146 anticoagulant agent Substances 0.000 title abstract 2
- 229940127219 anticoagulant drug Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000002429 anti-coagulating effect Effects 0.000 abstract 4
- 108090000190 Thrombin Proteins 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 229960004072 thrombin Drugs 0.000 abstract 3
- 108010039209 Blood Coagulation Factors Proteins 0.000 abstract 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 239000003114 blood coagulation factor Substances 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- GONFBOIJNUKKST-UHFFFAOYSA-N 5-ethylsulfanyl-2h-tetrazole Chemical compound CCSC=1N=NNN=1 GONFBOIJNUKKST-UHFFFAOYSA-N 0.000 abstract 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- 101000712605 Theromyzon tessulatum Theromin Proteins 0.000 abstract 1
- 229940122388 Thrombin inhibitor Drugs 0.000 abstract 1
- 239000012190 activator Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 230000015271 coagulation Effects 0.000 abstract 1
- 238000005345 coagulation Methods 0.000 abstract 1
- 238000011534 incubation Methods 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 239000003868 thrombin inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/974—Thrombin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
- G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60934090A | 1990-11-05 | 1990-11-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0509086T3 true DK0509086T3 (da) | 1995-07-03 |
Family
ID=24440379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92900357.2T DK0509086T3 (da) | 1990-11-05 | 1991-10-30 | Fremgangsmåde til bestemmelse af koncentrationen af antikoagulanter |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5702912A (fr) |
| EP (1) | EP0509086B1 (fr) |
| JP (1) | JP3094165B2 (fr) |
| AT (1) | ATE121139T1 (fr) |
| AU (1) | AU650941B2 (fr) |
| CA (1) | CA2070813C (fr) |
| DE (1) | DE69108896T2 (fr) |
| DK (1) | DK0509086T3 (fr) |
| ES (1) | ES2073908T3 (fr) |
| WO (1) | WO1992007954A1 (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4203980A1 (de) * | 1992-02-11 | 1993-08-12 | Max Planck Gesellschaft | Verfahren zur bestimmung von hirudin und synthetischen thrombininhibitoren |
| AT397391B (de) * | 1992-05-15 | 1994-03-25 | Immuno Ag | Verwendung von prothrombinfragmenten |
| US5308755A (en) * | 1992-06-08 | 1994-05-03 | Research Corporation Technologies, Inc. | Method for measuring heparin |
| CA2150552C (fr) * | 1993-09-30 | 1999-12-21 | Akikazu Takada | Antithrombotique |
| JPH11502222A (ja) * | 1995-03-23 | 1999-02-23 | キャンタブ ファーマシューティカルズ リサーチ リミティド | 遺伝子供給用ベクター |
| US6010911A (en) * | 1997-04-30 | 2000-01-04 | Medtronic, Inc. | Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique |
| US5985582A (en) * | 1997-12-09 | 1999-11-16 | Sigma-Aldrich Co. | Thrombin-based assay for antithrombin III |
| WO1999038997A1 (fr) * | 1998-01-30 | 1999-08-05 | Yoshitomi Pharmaceutical Industries, Ltd. | Procede de mesure de l'activite du cofacteur ii de l'heparine et boite de reactifs y relative |
| US6194394B1 (en) * | 1998-07-01 | 2001-02-27 | Sigma-Aldrich Co. | Coagulation controls for prothrombin time (PT) and activated partial thromboplastin time (APTT) assays |
| DE19904674A1 (de) * | 1999-02-04 | 2000-08-31 | Haemosys Gmbh | Verfahren zur Bestimmung der Konzentration von Thrombininhibitoren |
| AUPP971299A0 (en) | 1999-04-12 | 1999-05-06 | South Eastern Sydney Area Health Service | Procoagulant assay |
| EP1045250A1 (fr) * | 1999-04-12 | 2000-10-18 | INSTRUMENTATION LABORATORY S.p.A. | Test pour l'évaluation de la fonctionnalité du système thrombine/antithrombine |
| JP2003524187A (ja) * | 2000-02-23 | 2003-08-12 | ベッスト−テスト アンパーツゼルスカブ | 体液、例えば尿におけるマーカーと血液凝固活性とを相互関連づけるための方法 |
| US6680177B2 (en) * | 2001-12-07 | 2004-01-20 | Cardiovascular Diagnostics, Inc. | Low molecular weight heparin assay, system and reagent therefor |
| DE10330900B4 (de) * | 2003-07-01 | 2006-09-14 | Leibniz-Institut Für Polymerforschung Dresden E.V. | Biomaterial mit einem modularen Beschichtungssystem zur Anwendung in Medizinprodukten mit direktem Blutkontakt |
| EP1745145A4 (fr) * | 2004-05-11 | 2008-03-26 | Heptest Lab Inc | Compositions, kit et procede en une etape permettant de surveiller des composes possedant des activites d'antifacteur xa et/ou d'antifacteur iia |
| ES2375064T3 (es) | 2004-05-17 | 2012-02-24 | Medtronic, Inc. | Sistema de determinación de heparina en el lugar de atención al paciente. |
| WO2005117912A1 (fr) * | 2004-05-27 | 2005-12-15 | Avigen, Inc. | Procedes de traitement des troubles de saignement au moyen de polysaccharides sulfates |
| DE102005038418A1 (de) * | 2005-08-12 | 2007-02-15 | Dade Behring Marburg Gmbh | Faktor Xa-basierter Heparinassay unter Verwendung einer Heparin-modifizierenden Komponente |
| DE102006035580A1 (de) * | 2006-07-27 | 2008-02-14 | Csl Behring Gmbh | Bestimmung der biologischen Aktivität von Heparin in AT III-haltigen Präparationen |
| EP1918718A1 (fr) | 2006-10-31 | 2008-05-07 | Roche Diagnostics GmbH | Procédés et dispositifs destinés à la détermination électrochimique d'inhibiteurs du facteur Xa dans des échantillons sanguins |
| WO2009023538A1 (fr) * | 2007-08-10 | 2009-02-19 | Mayo Foundation For Medical Education And Research | Procédés et dispositifs de détection de la génération de thrombine |
| EP2471945A1 (fr) * | 2010-12-30 | 2012-07-04 | Siemens Healthcare Diagnostics Products GmbH | Procédé de détermination d'inhibiteurs de coagulation |
| JP6087775B2 (ja) * | 2013-09-13 | 2017-03-01 | 薫 梅野 | ハンドバイブレーターおよびハンドバイブレーター用連結具 |
| US11650196B2 (en) * | 2017-01-06 | 2023-05-16 | Sony Corporation | Blood coagulation system analysis apparatus, blood coagulation system analysis system, blood coagulation system analysis method, blood coagulation system analysis program, blood loss prediction apparatus, blood loss prediction system, blood loss prediction method, and blood loss prediction program |
| CN110514851A (zh) * | 2019-08-28 | 2019-11-29 | 深圳麦科田生物医疗技术有限公司 | 血小板抑制率的检测方法和检测试剂盒 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2812943C3 (de) * | 1978-03-23 | 1981-05-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma |
| DE3005540A1 (de) * | 1980-02-14 | 1981-08-20 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und reagens zur bestimmung der biologischen aktivitaet von heparin im plasma |
| WO1982001377A1 (fr) * | 1980-10-09 | 1982-04-29 | Lill Helmut | Procede de determination d'une bm ('binding moderately') antithrombine |
| US4473639A (en) * | 1982-09-15 | 1984-09-25 | Miles Laboratories, Inc. | Reagent strip test for antithrombin-III |
| US4851336A (en) * | 1985-09-05 | 1989-07-25 | Yin E Thye | Composition, kit, and method for assaying heparinano a method for making the composition |
| DE3536903A1 (de) * | 1985-10-16 | 1987-04-16 | Boehringer Mannheim Gmbh | Verfahren zur photometrischen bestimmung von protein c |
| IT1230744B (it) * | 1989-07-07 | 1991-10-29 | Instrumentation Lab Spa | Metodo per la determinazione della attivita' funzionale della proteina s nel plasma umano. |
| NL8902406A (nl) * | 1989-09-27 | 1991-04-16 | Hendrik Coenraad Hemker Prof D | Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit. |
-
1991
- 1991-10-30 DE DE69108896T patent/DE69108896T2/de not_active Expired - Lifetime
- 1991-10-30 ES ES92900357T patent/ES2073908T3/es not_active Expired - Lifetime
- 1991-10-30 AT AT92900357T patent/ATE121139T1/de not_active IP Right Cessation
- 1991-10-30 JP JP04501268A patent/JP3094165B2/ja not_active Expired - Lifetime
- 1991-10-30 DK DK92900357.2T patent/DK0509086T3/da active
- 1991-10-30 WO PCT/US1991/008117 patent/WO1992007954A1/fr active IP Right Grant
- 1991-10-30 CA CA002070813A patent/CA2070813C/fr not_active Expired - Fee Related
- 1991-10-30 EP EP92900357A patent/EP0509086B1/fr not_active Expired - Lifetime
-
1992
- 1992-01-09 AU AU10154/92A patent/AU650941B2/en not_active Ceased
-
1995
- 1995-11-30 US US08/564,986 patent/US5702912A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU650941B2 (en) | 1994-07-07 |
| AU1015492A (en) | 1992-06-25 |
| CA2070813A1 (fr) | 1992-05-06 |
| WO1992007954A1 (fr) | 1992-05-14 |
| CA2070813C (fr) | 1996-10-29 |
| EP0509086B1 (fr) | 1995-04-12 |
| US5702912A (en) | 1997-12-30 |
| JP3094165B2 (ja) | 2000-10-03 |
| ES2073908T3 (es) | 1995-08-16 |
| DE69108896T2 (de) | 1995-08-24 |
| JPH05503223A (ja) | 1993-06-03 |
| ATE121139T1 (de) | 1995-04-15 |
| EP0509086A1 (fr) | 1992-10-21 |
| DE69108896D1 (de) | 1995-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0509086T3 (da) | Fremgangsmåde til bestemmelse af koncentrationen af antikoagulanter | |
| US20090087870A1 (en) | Hematological assay and kit | |
| EP0632270A4 (fr) | Procede de determination de l'activite du facteur de coagulation sanguine xiii et trousse de reactifs appropries. | |
| ATE35000T1 (de) | Reagenz zur bestimmung der thromboplastinzeit. | |
| Kahle et al. | Antithrombin III I. Evaluation of an automated antithrombin III method | |
| ATE315233T1 (de) | Verfahren zur bestimmung des antikoagulatorischen potentials einer probe und verfahren zur bestimmung der glykosilierung von thrombomodulin | |
| AU694931B2 (en) | A method for detecting disturbances of the protein C/protein S system | |
| DK0830608T3 (da) | Thromboseriskotest | |
| US4918001A (en) | Method for the determination of protease inhibitors | |
| EP0567636B1 (fr) | Dosage de la proteine s | |
| DK0626070T3 (da) | Fremgangsmåde til bestemmelse af hirudin og syntetiske thrombininhibitorer | |
| DK62186A (da) | Fremgangsmaade til bestemmelse af prokallikrein | |
| Calatzis et al. | The prothrombinase-induced clotting test: A new technique for the monitoring of anticoagulants | |
| EP0491895B1 (fr) | DOSAGE CHROMOGENIQUE SERVANT A DETERMINER LE FACTEUR VIII:Ca | |
| NO20061240L (no) | Fremgangsmate for detektering av prokoagulant fosfolipid | |
| US7923217B2 (en) | Specificity in the determination of antithrombin | |
| Hellstern et al. | Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode | |
| Clatzis et al. | The prothrombinase-induced clotting test: a new technique for the monitoring of anticoagulants |